| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |